Live Status Check

NCT05004987 Recruiting Status

Real-time enrollment status for this i cannot determine the primary medical condition from the provided information. the study title "aβ dynamics in llmd" uses abbreviations that are unclear, the conditions section only lists drugs (escitalopram oxalate and placebo), and the brief summary appears to be incomplete (showing only a localhost url). without more specific information about what medical condition this trial is investigating, i cannot provide the patient-facing condition that people would search for. clinical trial

Current Status

Recruiting

Auto-verified from ClinicalTrials.gov

Checked: March 2, 2026 at 12:06 PM UTC

NCT05004987 Status Summary

NCT NumberNCT05004987
Recruiting StatusRecruiting
ConditionI cannot determine the primary medical condition from the provided information. The study title "Aβ Dynamics in LLMD" uses abbreviations that are unclear, the conditions section only lists drugs (Escitalopram Oxalate and Placebo), and the brief summary appears to be incomplete (showing only a localhost URL). Without more specific information about what medical condition this trial is investigating, I cannot provide the patient-facing condition that people would search for.
PhaseClinical Trial
Target Enrollment60 participants
Active Locations2 sites in the US
SponsorNYU Langone Health
Last Updated on CT.govJune 8, 2025 (Jun 8, 2025)

About NCT05004987 Enrollment Status

As of March 2, 2026: Clinical trial NCT05004987 is currently recruiting participants. This clinical trial study for i cannot determine the primary medical condition from the provided information. the study title "aβ dynamics in llmd" uses abbreviations that are unclear, the conditions section only lists drugs (escitalopram oxalate and placebo), and the brief summary appears to be incomplete (showing only a localhost url). without more specific information about what medical condition this trial is investigating, i cannot provide the patient-facing condition that people would search for. is actively seeking new participants at 2 locations across the United States. The study is sponsored by NYU Langone Health. This status information is automatically verified from the official ClinicalTrials.gov registry.

Frequently Asked Questions About NCT05004987

Is NCT05004987 still recruiting?

Yes, NCT05004987 is actively recruiting participants as of March 2, 2026. You can check eligibility and apply through HelloStudys.

Where is NCT05004987 recruiting?

This trial is recruiting at 2 locations in the United States. View all available locations on the full study page.

How do I enroll in NCT05004987?

Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.

When was NCT05004987 status last updated?

The official ClinicalTrials.gov record for NCT05004987 was last updated Jun 8, 2025 (June 8, 2025). HelloStudys verifies this status automatically.

Browse More I cannot determine the primary medical condition from the provided information. The study title "Aβ Dynamics in LLMD" uses abbreviations that are unclear, the conditions section only lists drugs (Escitalopram Oxalate and Placebo), and the brief summary appears to be incomplete (showing only a localhost URL). Without more specific information about what medical condition this trial is investigating, I cannot provide the patient-facing condition that people would search for. Trials

Ready to Apply?

Check your eligibility for this clinical trial